News | May 17, 2010

ACR, Radiation Oncologists to Speak to FDA at Dose Meeting

May 17, 2010 - The radiation oncology community will discuss steps manufacturers of linear accelerators, radiation therapy treatment planning systems and radiation therapy simulators can take to help reduce misadministration and misaligned exposures.

The discussion will take place at a public meeting, "Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures From Therapeutic Radiation," held by the U.S. Food and Drug Administration (FDA), June 9-10, 2010, 8:00 a.m., at the Hilton Hotel Washington, D.C., North in Gaithersburg, Md.

Albert L. Blumberg, M.D., FACR, chair of the American College of Radiology (ACR) Commission on Radiation Oncology, James Hevezi, Ph.D., FACR, chair of the ACR Medical Physics Commission, and Indra J. Das, Ph.D., FACR, ACR radiation oncology program surveyor, will speak on behalf of the ACR at the meeting.

Several ACR members and staff are expected to take part in the meeting. The College will keep members informed of major developments regarding this very important issue.

For more information: http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm211...

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation